Genmab (GMAB) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Genmab A/S, a Copenhagen-based company, has authorized its Board of Directors to increase the share capital by up to DKK 6,600,000 and issue warrants for employees, excluding executives, until 2029. The company is also permitted to issue convertible debt instruments, allowing for a potential further increase in share capital. These strategic financial maneuvers are designed to support Genmab’s ongoing medical research and business operations.
For further insights into GMAB stock, check out TipRanks’ Stock Analysis page.
